Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Tetsuo, Takuma"'
Autor:
Ikuro Matsuba, Takehiro Kawata, Kotaro Iemitsu, Taro Asakura, Hikaru Amemiya, Masashi Ishikawa, Syogo Ito, Mizuki Kaneshiro, Akira Kanamori, Akira Kubota, Kazuaki Shinoda, Masahiko Takai, Tetsuo Takuma, Masahiro Takihata, Hiroshi Takeda, Keiji Tanaka, Yoko Matsuzawa, Hideo Machimura, Fuyuki Minagawa, Nobuaki Minami, Atsuko Mokubo, Masaaki Miyakawa, Yasuo Terauchi, Yasushi Tanaka
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Abstract Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in w
Externí odkaz:
https://doaj.org/article/ef16d02909194cbd8964f418883bb465
Autor:
Ikuro, Matsuba, Tetsuo, Takuma, Nobuo, Hatori, Masahiko, Takai, Yoshiyuki, Watanabe, Nobukazu, Takada, Satoru, Kishi, Yoko, Matsuzawa, Tetsuo, Nishikawa, Tomoyuki, Kunishima, Hisakazu, Degawa, Masanori, Nishikawa, Yoshiaki, Ono, Masaaki, Miyakawa, Yutaka, Hatori, Akira, Kanamori
Publikováno v:
Internal Medicine. 61:3053-3062
Objective To examine the continuation of antibody prevalence status after 12 months and background factors in antibody-positive subjects following asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods We in
Autor:
Yoshiyuki Watanabe, Ikuro Matsuba, Karin Watanabe, Tomoyuki Kunishima, Yukako Takechi, Tetsuo Takuma, Yasushi Araki, Nobuo Hirotsu, Hiroyuki Sakai, Ritsuko Oikawa, Hiroki Danno, Masakazu Fukuda, Seiji Futagami, Kota Wada, Hiroyuki Yamamoto, Fumio Itoh, Ichiro Oda, Yutaka Hatori, Hisakazu Degawa
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic even after vaccination. We aimed to identify immunological heterogeneity over time in vaccinated healthcare workers usi
Autor:
Akira Kanamori, Masahiro Takihata, Kotaro Iemitsu, Hikaru Amemiya, Mizuki Kaneshiro, Yoko Matsuzawa, Masashi Ishikawa, Keiji Tanaka, Hiroshi Takeda, Kazuaki Shinoda, Akira Kubota, Takehiro Kawata, Tetsuo Takuma, Nobuaki Minami, Yasushi Tanaka, Hideo Machimura, Ikuro Matsuba, Atsuko Mokubo, Masaaki Miyakawa, Masahiko Takai, Yasuo Terauchi, Syogo Ito, Taro Asakura, Fuyuki Minagawa
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1248-1257 (2020)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long‐term treatments are available. Methods This was an investigator‐initiated multicenter prospective intervention study in which ipra
Autor:
Atsuko Mokubo, Masahiko Takai, Mizuki Kaneshiro, Takehiro Kawata, Akira Kanamori, Yasushi Tanaka, Tetsuo Takuma, Ikuro Matsuba, Akira Kubota, Mitsuo Obana, Shinichi Umezawa, Taisuke Kikuchi, Hideo Machimura, Hiroshi Takeda, Yoko Matsuzawa, Tetsuya Motomiya, Masahiro Takihata, Kotaro Iemitsu, Hajime Maeda, Masaaki Miyakawa, Shogo Ito, Yasuo Terauchi, Taro Asakura
Publikováno v:
Diabetes Technology & Therapeutics. 22:228-234
Background: Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been repo...
Autor:
Akira Kanamori, Tetsuya Motomiya, Masahiko Takai, Hiroshi Takeda, Kotaro Iemitsu, Atsuko Mokubo, Hajime Maeda, Fuyuki Minagawa, Akira Kubota, Masashi Ishikawa, Takehiro Kawata, Tetsuo Takuma, Shinichi Umezawa, Keiji Tanaka, Hideo Machimura, Ikuro Matsuba
Publikováno v:
Journal of Clinical Medicine Research
Background: There are several reports of seasonal variation in hemoglobin A1c (HbA1c) in patients with type 2 diabetes (T2DM), but no reports of seasonal variation in the effect of add-on drugs on blood glucose control in insulin-treated patients. Me
Autor:
Akira Kanamori, Tomoyuki Kunishima, Nobuo Hatori, Hisakazu Degawa, Masahiko Takai, Tetsuo Nishikawa, Ikuro Matsuba, Nobukazu Takada, Yoko Matsuzawa, Yoshiyuki Watanabe, Yoshiaki Ono, Masanori Nishikawa, Tetsuo Takuma, Satoru Kishi
Publikováno v:
Internal medicine (Tokyo, Japan). 61(2)
Objective To examine the continuation of antibody prevalence and background factors in antibody-positive subjects after asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods A study was carried out to inves
Autor:
Hajime Maeda, Tetsuya Motomiya, Takehiro Kawata, Shinichi Umezawa, Kotaro Iemitsu, Akira Kubota, Masaaki Miyakawa, Mizuki Kaneshiro, Masahiko Takai, Mitsuo Obana, Tetsuo Takuma, Hideo Machimura, Hiroshi Takeda, Shogo Ito, Akira Kanamori, Taisuke Kikuchi, Yoko Matsuzawa, Ikuro Matsuba, Yasuo Terauchi, Atsuko Mokubo, Taro Asakura, Masahiro Takihata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f478f05116b4316eee572e538c60084f
https://doi.org/10.1111/dom.14508/v2/response1
https://doi.org/10.1111/dom.14508/v2/response1
Autor:
Mitsuo Obana, Masaaki Miyakawa, Tetsuya Motomiya, Yasuo Terauchi, Shogo Ito, Taro Asakura, Atsuko Mokubo, Kotaro Iemitsu, Hideo Machimura, Masahiko Takai, Hajime Maeda, Akira Kanamori, Taisuke Kikuchi, Shinichi Umezawa, Akira Kubota, Yoko Matsuzawa, Tetsuo Takuma, Ikuro Matsuba, Masahiro Takihata, Takehiro Kawata, Mizuki Kaneshiro, Hiroshi Takeda
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(12)
Aim Long-term changes in body composition associated with SGLT2 inhibitors have not been characterized. Materials and methods In this multicenter, single-arm, open-label study, 107 subjects with type 2 diabetes were treated, as add-on therapy, with c
Autor:
Nobuo Sasai, Tetsuya Motomiya, Kotaro Iemitsu, Hajime Maeda, Atsuko Mokubo, Hikaru Amemiya, Hiroshi Takeda, Akira Kanamori, Tomoyuki Iwasaki, Takehiro Kawata, Hideaki Kaneshige, Takashi Iizuka, Fuyuki Minagawa, Masashi Ishikawa, Goro Uehara, Mizuki Kaneshiro, Yasushi Tanaka, Tatsuya Saito, Keiji Tanaka, Yasuo Terauchi, Ikuro Matsuba, Nobuaki Minami, Hideo Machimura, Shin Honda, Shigeru Nakajima, Mitsuo Obana, Masaaki Miyakawa, Yukiko Miyairi, Kazuhiko Hoshino, Masahiko Takai, Manabu Waseda, Akira Kubota, Kiyokazu Matoba, Tetsuo Takuma, Shinichi Umezawa
Publikováno v:
Journal of Clinical Medicine Research
Background: Sitagliptin, the first dipeptidyl peptidase-4 inhibitor, has demonstrated efficacy and safety as monotherapy and as add-on therapy to oral antidiabetic agents or insulin. However, there have been few reports about sitagliptin in elderly p